The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The incidence and risks of adverse events in randomized controlled trials (RCTs) of cancer drugs downplaying the harms.
 
Bishal Gyawali
No Relationships to Disclose
 
Kazunori Honda
No Relationships to Disclose
 
Tomoya Shimokata
No Relationships to Disclose
 
Yuichi Ando
Honoraria - ARKRAY; ASKA Pharmaceutical; Bayer Holding; Benesse Style Care; Bristol-Myers Squibb; Chugai Pharma; Eisai; EPS Associates Co., Ltd.; Hisamitsu Pharmaceutical; Kowa; Kyowa Hakko Kirin; Lilly Japan; Mochida Pharmaceutical Co. Ltd.; Nippon Kayaku; Novartis; Ono Pharmaceutical; Otsuka; Pharma International; Sawai Pharmaceutical Co; Shionogi; Taiho Pharmaceutical; Takeda; TERUMO; Yakult Honsha
Consulting or Advisory Role - Daiichi Sankyo; GlaxoSmithKline; ICON Clinical Research; Kowa; Novartis; Ono Pharmaceutical; PAREXEL; Sun Pharma
Research Funding - Chugai Pharma; Eisai; Hisamitsu Pharmaceutical; Kyowa Hakko Kirin; Lilly Japan; Merck Serono; Mochida Pharmaceutical Co. Ltd.; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha